Vanguard Group
HTGM

Vanguard Group’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,692
Closed -$39.7K 4641
2023
Q1
$39.7K Buy
+14,692
New +$39.7K ﹤0.01% 4490
2022
Q4
Sell
-70,922
Closed -$43K 4581
2022
Q3
$43K Sell
70,922
-4,495
-6% -$2.73K ﹤0.01% 4559
2022
Q2
$78K Sell
75,417
-170,349
-69% -$176K ﹤0.01% 4563
2022
Q1
$341K Hold
245,766
﹤0.01% 4454
2021
Q4
$1.33M Sell
245,766
-300
-0.1% -$1.63K ﹤0.01% 4177
2021
Q3
$1.41M Buy
246,066
+2,741
+1% +$15.7K ﹤0.01% 4166
2021
Q2
$1.41M Buy
243,325
+135,298
+125% +$786K ﹤0.01% 4071
2021
Q1
$591K Buy
108,027
+25,425
+31% +$139K ﹤0.01% 4106
2020
Q4
$396K Sell
82,602
-1,231,394
-94% -$5.9M ﹤0.01% 4000
2020
Q3
$434K Sell
1,313,996
-320,204
-20% -$106K ﹤0.01% 3838
2020
Q2
$1.18M Sell
1,634,200
-4,355
-0.3% -$3.14K ﹤0.01% 3570
2020
Q1
$533K Hold
1,638,555
﹤0.01% 3659
2019
Q4
$1.15M Buy
1,638,555
+279,900
+21% +$196K ﹤0.01% 3605
2019
Q3
$924K Sell
1,358,655
-94,505
-7% -$64.3K ﹤0.01% 3671
2019
Q2
$2.41M Buy
1,453,160
+242,497
+20% +$403K ﹤0.01% 3417
2019
Q1
$3.03M Buy
1,210,663
+82,138
+7% +$205K ﹤0.01% 3323
2018
Q4
$2.87M Buy
1,128,525
+45,851
+4% +$116K ﹤0.01% 3267
2018
Q3
$5.47M Hold
1,082,674
﹤0.01% 3199
2018
Q2
$3.53M Buy
1,082,674
+153,695
+17% +$501K ﹤0.01% 3327
2018
Q1
$3.36M Buy
928,979
+587,788
+172% +$2.13M ﹤0.01% 3289
2017
Q4
$692K Buy
341,191
+96,639
+40% +$196K ﹤0.01% 3686
2017
Q3
$416K Buy
244,552
+109,318
+81% +$186K ﹤0.01% 3786
2017
Q2
$359K Buy
135,234
+37,841
+39% +$100K ﹤0.01% 3786
2017
Q1
$674K Buy
97,393
+25,635
+36% +$177K ﹤0.01% 3684
2016
Q4
$161K Buy
71,758
+400
+0.6% +$897 ﹤0.01% 3922
2016
Q3
$166K Sell
71,358
-3,642
-5% -$8.47K ﹤0.01% 3929
2016
Q2
$195K Hold
75,000
﹤0.01% 3955
2016
Q1
$216K Sell
75,000
-550
-0.7% -$1.58K ﹤0.01% 3943
2015
Q4
$329K Buy
75,550
+1,300
+2% +$5.66K ﹤0.01% 3917
2015
Q3
$566K Hold
74,250
﹤0.01% 3811
2015
Q2
$828K Buy
+74,250
New +$828K ﹤0.01% 3716